Want to stay updated on the latest news?
Create a Reader Account today to follow the industries and companies that interest you, and customize your news dashboard. SIGN INTO READER ACCOUNT CREATE READER ACCOUNT
Dyadic to Report 2022 Year End Financial Results on Wednesday, March 29, 2023
March 15, 2023 08:30 ET
|
Dyadic International, Inc.
JUPITER, Fla., March 15, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building...
Cytovance Biologics and Phenotypeca Collaborate to Enhance Saccharomyces cerevisiae Strain Development for Microbial Biomanufacturing
March 11, 2023 07:00 ET
|
Cytovance Biologics
OKLAHOMA CITY, March 11, 2023 (GLOBE NEWSWIRE) -- Cytovance Biologics, Inc. (Cytovance Biologics), a biopharmaceutical contract development and manufacturing organization (CDMO), and Phenotypeca...
BioP2P Network Names Scientific Advisory Board to Guide Efforts to Fuel Growing U.S. Bioeconomy
March 08, 2023 05:15 ET
|
California Biomanufacturing Center
VACAVILLE, Calif., March 08, 2023 (GLOBE NEWSWIRE) -- The BioProcess to Product (BIOP2P) Network, a national program to accelerate the transformation of manufacturing in the United States for the...
Dyadic to Present at Roth Investor Conference and Upcoming Industry Events
March 01, 2023 08:30 ET
|
Dyadic International, Inc.
JUPITER, Fla., March 01, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building innovative microbial...
Green Bioactives engages biomanufacturing expert John Stevenson to lead production scale-up
February 21, 2023 02:30 ET
|
Green Bioactives Limited
Edinburgh, Scotland, 21 February 2023 – Green Bioactives Limited (‘GBL’), a world-leader in the discovery, development and sustainable production of high-value natural products derived from plant cell...
Dyadic to Participate in Two Upcoming Investor Conferences
February 02, 2023 08:30 ET
|
Dyadic International, Inc.
JUPITER, Fla., Feb. 02, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building innovative microbial...
Premiere Synthetic Biology Event on Track for Record Attendance - 2023
February 01, 2023 14:36 ET
|
SynBioBeta
SynBioBeta Global Synthetic Biology Conference Registration Open SynBioBeta announces event dates, keynotes, sponsors, and location SAN FRANCISCO, Feb. 01, 2023 (GLOBE NEWSWIRE) --...
BioP2P Network Launches Online Biomanufacturing Career Center
January 31, 2023 08:15 ET
|
California Biomanufacturing Center
VACAVILLE, Calif., Jan. 31, 2023 (GLOBE NEWSWIRE) -- The BioProcess to Product (BioP2P) Network, a national nonprofit program working to accelerate the transformation of manufacturing in the United...
Dyadic Announces Initiation of Dosing of First-In-Human Phase 1 Trial to Demonstrate Clinical Safety and Antibody Response in Humans for DYAI-100 COVID-19 Recombinant Protein RBD Booster Vaccine Candidate
January 24, 2023 08:30 ET
|
Dyadic International, Inc.
JUPITER, Fla., Jan. 24, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building...
Liberation Labs Selects Indiana for First Biomanufacturing Facility
January 24, 2023 07:00 ET
|
Liberation Labs
RICHMOND, Ind., Jan. 24, 2023 (GLOBE NEWSWIRE) -- Liberation Labs, a large-scale precision fermentation manufacturer, has executed a purchase agreement for the site of its first commercial-scale...